Is Lophomonas a Pathogen?
Editors in Conversation
by Bobbi Pritt, Abhishek Mewara, Alex McAdam, Elli Theel
1M ago
The protozoan Lophomonas has been reported to be a pathogen of humans in a large number of case reports and case series. Most of these case reports describe infections of the respiratory tract. Editors in Conversation is joined by two experts to discuss this possible parasite. Some of the questions addressed include: What are the characteristics of the species in the genus Lophomonas? What are the laboratory and morphological data that suggest that Lophomonas species cause human infections? What are the purported clinical manifestations of Lophomonas? Finally, is Lophomonas truly a pathogen o ..read more
Visit website
New generation B-lactam/B-lactamase inhibitors: Taniborbactam
Editors in Conversation
by Cesar Arias, Alejandro Vila, Pranita Tamma, Robert Bonomo
3M ago
A new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year. These broad-spectrum inhibitors exhibit activity against the most feared class B metallo-B-lactamases maintaining the inhibition of other enzymes. Recently AAC has published three papers that describe the mechanistic bases of taniborbactam resistance among metallo-enzymes. This knowledge is crucial to understand the limitation of these compounds in clinical practice. Today, we will discuss this topic with some of the authors of the mentioned papers. Welcome to the editors in conversation. Topics disc ..read more
Visit website
Favorite Clinical Microbiology Papers of 2023 (JCM ed.)
Editors in Conversation
by Melissa Miller, Patricia Simner, Alex McAdam, Elli Theel
4M ago
We managed to make it through 2023 without a major epidemic or pandemic, and as we get into the holiday spirit and look forward to the new year, some of us took a look back and picked out one of our favorite JCM paper published in 2023, which I will tell you, was no easy task as there were many of good ones to choose from! And personally, after looking through all the issues over the last year, it never ceases to amaze me the variety of topics that we publish on in JCM – including unique things like the evaluation of a molecular assay for diagnosis of Buruli ulcers, to development of an EIA fo ..read more
Visit website
Antimicrobial Resistance in Neisseria Gonorrhoeae (JCM ed.)
Editors in Conversation
by Tanis Dingle, Angela Ma, Alex McAdam, Elli Theel
4M ago
Gonorrhea remains one of the more common sexually transmitted infections. In North America, the number of reported cases has generally risen for over ten years, with interruptions in the early days of the COVID-19 pandemic, followed by returns to rising rates of infection. Under the selective pressure of antimicrobial treatment, antimicrobial resistance has risen, which has led to limited options for treatment Today, we will be discussing antimicrobial resistance in N. gonorrhoeae, including these questions:     •    How accurate is gradient diffusion susceptibili ..read more
Visit website
New Antifungals (AAC Ed.)
Editors in Conversation
by Cesar Arias, Andreas Groll
5M ago
In the last few years we have witnessed the rise of very resistant fungal species some of them likely influenced by environmental conditions and climate change. Fortunately, there has been a bit of an explosion in the development of new antifungals and the pipeline has been strengthened in the last decade. We will have the ability to have new molecules with distinct and novel mechanisms of action in the near future that may contribute to combat recalcitrant fungal infections. Topics discussed: The overall threat of fungal resistance. The antifungal pipeline in the last few years. New promisin ..read more
Visit website
A Novel Coccidioides Antibody LFA (JCM ed.)
Editors in Conversation
by Elli Theel, Alex McAdam, Tom Grys, Francisca Grill
6M ago
Despite the many advances in diagnostic testing for infectious diseases, detection of Coccidoides infections continues to rely on serologic assessment for anti-fungal antibodies, and what is perhaps more astonishing is that the serologic methods we use today, such as complement fixation and immunodiffusion, were first developed about a century ago. These assays are technically challenging to maintain and perform, and as a result few labs offer this testing, and even if performed on-site, testing can take up to 3 days complete, so there is definitely room for improvement. So today, we are talki ..read more
Visit website
Artificial Intelligence and Infectious Diseases
Editors in Conversation
by Cesar Arias, Lilian Abbo, Masayuki Nigo
7M ago
Artificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures. AAC recently published a commentary on the impact of AI in infectious diseases and we have a conversation with the lead author of the manuscript and a expert guest who is applying these concepts in real time.    Topics discussed: Basic concepts of AI and different appl ..read more
Visit website
Viral Outbreaks in the Headlines (JCM ed.)
Editors in Conversation
by Elli Theel, Alex McAdam, Ben Pinsky, Ryan Relich
8M ago
Dr. Elli Theel and Dr. Alex McAdam discuss recent viral outbreaks with expert virologists. Recorded before a live audience at ASM Microbe 2023. Topics: What are the recent epidemiologic and diagnostic findings with Mpox?  What are the reservoirs for influenza A H5N1 and how is it transmitted to humans? Why was there such a large number of cases of human metapneumovirus this past respiratory virus season? Guests: Dr. Ben Pinsky, Director of the Clinical Virology laboratory and Professor of Pathology and Medicine at Stanford Health Care and the Stanford University School of Medicine Dr ..read more
Visit website
AAC Launches a New Section Focused On Antimicrobial Stewardship
Editors in Conversation
by Cesar Arias, Pranita Tamma, Ryan Shields
9M ago
In response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and reducing the subsequent emergence of AMR, Antimicrobial Agents and Chemotherapy is excited to add a new section to the journal focused on antimicrobial stewardship studies. Combatting the devastating burden of AMR requires novel, multipronged approaches from clinicians and scientists alike. Launching this new section is an important step in disseminating cutting-edge research that will have notable implications in the global fight against ant ..read more
Visit website
Hispanic Leadership in Vaccine Sciences With Dr. Maria Elena Bottazzi (AAC ed.)
Editors in Conversation
by Cesar Arias, Maria Elena Bottazzi
10M ago
Recorded at ASM Microbe 2023, Cesar has a conversation with Dr. Maria Elena Bottazzi about the role of minority women in science and discovery, the journey of Hispanic women in science and the current challenges posed by society to deliver science and global health equity. Guest: Dr. Maria Elena Bottazzi - Sr. Associate Dean of the National School of Tropical Medicine at Baylor College of Medicine, Distinguished Professor of Biology at Baylor University, Waco This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at aac.asm.org. If you plan to publish i ..read more
Visit website

Follow Editors in Conversation on FeedSpot

Continue with Google
Continue with Apple
OR